logo
搜索
菜单

的搜索结果

当前419/788页
排序: 最近更新
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model 01:15 min
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model 01:15 min
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model
15.10: Pharmacodynamic Models: Emax Drug–Concentration Effect Model 01:18 min
15.10: Pharmacodynamic Models: Emax Drug–Concentration Effect Model
15.9: Pharmacodynamic Models: Overview 01:27 min
15.9: Pharmacodynamic Models: Overview
15.8: Pharmacodynamic Responses: Different Types 01:03 min
15.8: Pharmacodynamic Responses: Different Types
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.5: Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration 01:23 min
15.5: Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship 01:23 min
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
15.3: Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship 01:14 min
15.3: Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
14.9: Pharmacogenomics: Identification of New Drug Targets 01:29 min
14.9: Pharmacogenomics: Identification of New Drug Targets
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase 01:11 min
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters 01:16 min
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
14.6: Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase 01:27 min
14.6: Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes 01:28 min
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
14.4: Pharmacogenetics of Drug Metabolism: Overview 01:27 min
14.4: Pharmacogenetics of Drug Metabolism: Overview
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu 01:29 min
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
14.2: Principles of Pharmacogenetics: Types of Genetic Variants 01:27 min
14.2: Principles of Pharmacogenetics: Types of Genetic Variants
返回顶部